Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Jubilant Ingrevia Ltd. ( (IN:JUBLINGREA) ) has shared an announcement.
Jubilant Ingrevia Limited has signed a share purchase agreement to acquire 100% of Remidex Pharma Private Limited, a Bengaluru-based manufacturer of micronutrient premixes, nutraceuticals, and a contract manufacturer for major Indian and multinational pharmaceutical companies. The deal, completed on March 13, 2026, will make Remidex a wholly owned subsidiary and is intended to advance Jubilant Ingrevia further along the human nutrition value chain by adding premix capabilities that complement its established leadership in vitamins, potentially strengthening its market position and product portfolio in the nutrition and pharmaceutical sectors.
More about Jubilant Ingrevia Ltd.
Jubilant Ingrevia Limited operates in the specialty chemicals and life sciences industry, with a strong presence in vitamins such as Vitamin B3 and B4. The company focuses on value-added products in human nutrition and related segments, aiming to move up the value chain through strategic expansions and acquisitions.
Average Trading Volume: 14,940
Technical Sentiment Signal: Hold
Current Market Cap: 92.05B INR
Learn more about JUBLINGREA stock on TipRanks’ Stock Analysis page.